FREE - Register to access one 3D Animation Video and Interactive Test from each of the
3 CME credits. This course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with European CME Credits (ECMEC®s) and by
the Postgraduate Institute for Medicine with
AMA PRA Category 1 Credits™.
9 CPD credits. This subject is approved by the Royal Society of Biology.
Cancer Immunotherapy uses components of the immune system to modify the immune response. In Subject 08, we explore how Immunotherapy provides different strategies to fight tumors, such as the application of Monoclonal Antibodies directed against tumor antigens and Immune Checkpoints, or the stimulation of the immune cells, either directly or by means of tumor antigens, and by adoptive cell therapy. You will discover its mechanisms of action at the cellular and molecular levels and gain insights into the possibilities of immunotherapy in treating cancer.
What will you learn?
With this course you
will learn about:
Tumor Antigens: Tumor Specific Antigens (TSA) and Tumor Associated Antigens (TAA).
Monoclonal Antibodies (mAb), Immunoconjugated monoclonal antibodies and Bispecific monoclonal antibodies.
Immune checkpoint inhibitors.
Adoptive Cell Therapy: Adoptive dendritic cell transfer and Adoptive T cell transfer.
Reset deadlines in accordance to your schedule. You will have 12 months to do the
course in your own pace.
Approx. 4 hours to complete
We recommend to dedicate 2 hours per week to complete the course in 2 weeks.
Start instantly and learn at your own schedule.
All course materials are in English. Customer attention: English and Spanish.